Reference
Georgalas I, et al. Renal Injury Following Intravitreal Anti-VEGF Administration in Diabetic Patients with Proliferative Diabetic Retinopathy and Chronic Kidney Disease - A Possible Side Effect? Current Drug Safety 9: 156-158, No. 2, 2014 - Greece
Rights and permissions
About this article
Cite this article
Bevacizumab/ranibizumab. Reactions Weekly 1515, 46 (2014). https://doi.org/10.1007/s40278-014-2741-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-2741-1